TY - JOUR
T1 - Intra- and interlaboratory performances of two commercial antimicrobial susceptibility testing methods for bifidobacteria and nonenterococcal lactic acid bacteria
AU - Huys, Geert
AU - D'Haene, Klaas
AU - Cnockaert, Marco
AU - Tosi, Lorenzo
AU - Danielsen, Morten
AU - Belén Flórez, Ana
AU - Mättö, Jaana
AU - Axelsson, Lars
AU - Korhonen, Jenni
AU - Mayrhofer, Sigrid
AU - Egervärn, Maria
AU - Giacomini, Mauro
AU - Vandamme, Peter
PY - 2010
Y1 - 2010
N2 - In a small-scale harmonization study involving nine laboratories in
eight European countries, the intra- and interlaboratory performances of
two commercially available systems, i.e., the VetMIC microplate system
and Etest, for antimicrobial susceptibility testing of nonenterococcal
lactic acid bacteria (NELAB) and bifidobacteria were analyzed. In
addition, one laboratory also performed standard broth microdilution as a
reference method. MICs of tetracycline, erythromycin, ampicillin,
gentamicin, clindamycin, and streptomycin for the type strains of 25
species of NELAB and bifidobacteria and MICs of vancomycin for a
selection of relevant taxa were determined. The previously described
lactic acid bacterium susceptibility test medium (LSM) and related
mixed-medium formulations, all including Iso-Sensitest broth as a basic
component, were used as test media. The overall agreement of median MIC
ranges ± 1 log2 dilution determined by the VetMIC and Etest
methods with the median MICs determined by the reference method was very
good for tetracycline, ampicillin, and streptomycin (92.3 to 100%) but
low for erythromycin (19.5 to 30.7%) and clindamycin (50.0 to 80.8%).
There was a consensus among the participating laboratories that VetMIC
was preferred over Etest because of its lower cost, better growth
support, and more uniform criteria for MIC end point reading. With the
range for acceptable intralaboratory reproducibility being defined as
the median MIC ± 1 log2 dilution, VetMIC results (with 69.2%
of all data sets in the acceptable range) were shown to display greater
reproducibility than Etest results (with 58.8% of all data sets in the
acceptable range). Also at the interlaboratory level, the proportion of
MIC values obtained with VetMIC that belonged to the complete agreement
category (60.0%) was higher than the proportion of such values obtained
with Etest (47.0%), which indicates a higher degree of interlaboratory
reproducibility for the former method. Apart from some agent-specific
effects, the majority of VetMIC and Etest replicate data sets were
situated within a 1- to 2-log2 dilution range, suggesting
that the two methods can be considered to be equivalent for recognizing
resistance phenotypes. This multicenter study has further validated the
standard use of LSM and related mixed-medium formulations with
commercially available systems and formed the basis for the ongoing
development of the ISO 10932/IDF 223 standard for susceptibility testing
of NELAB and bifidobacteria.
AB - In a small-scale harmonization study involving nine laboratories in
eight European countries, the intra- and interlaboratory performances of
two commercially available systems, i.e., the VetMIC microplate system
and Etest, for antimicrobial susceptibility testing of nonenterococcal
lactic acid bacteria (NELAB) and bifidobacteria were analyzed. In
addition, one laboratory also performed standard broth microdilution as a
reference method. MICs of tetracycline, erythromycin, ampicillin,
gentamicin, clindamycin, and streptomycin for the type strains of 25
species of NELAB and bifidobacteria and MICs of vancomycin for a
selection of relevant taxa were determined. The previously described
lactic acid bacterium susceptibility test medium (LSM) and related
mixed-medium formulations, all including Iso-Sensitest broth as a basic
component, were used as test media. The overall agreement of median MIC
ranges ± 1 log2 dilution determined by the VetMIC and Etest
methods with the median MICs determined by the reference method was very
good for tetracycline, ampicillin, and streptomycin (92.3 to 100%) but
low for erythromycin (19.5 to 30.7%) and clindamycin (50.0 to 80.8%).
There was a consensus among the participating laboratories that VetMIC
was preferred over Etest because of its lower cost, better growth
support, and more uniform criteria for MIC end point reading. With the
range for acceptable intralaboratory reproducibility being defined as
the median MIC ± 1 log2 dilution, VetMIC results (with 69.2%
of all data sets in the acceptable range) were shown to display greater
reproducibility than Etest results (with 58.8% of all data sets in the
acceptable range). Also at the interlaboratory level, the proportion of
MIC values obtained with VetMIC that belonged to the complete agreement
category (60.0%) was higher than the proportion of such values obtained
with Etest (47.0%), which indicates a higher degree of interlaboratory
reproducibility for the former method. Apart from some agent-specific
effects, the majority of VetMIC and Etest replicate data sets were
situated within a 1- to 2-log2 dilution range, suggesting
that the two methods can be considered to be equivalent for recognizing
resistance phenotypes. This multicenter study has further validated the
standard use of LSM and related mixed-medium formulations with
commercially available systems and formed the basis for the ongoing
development of the ISO 10932/IDF 223 standard for susceptibility testing
of NELAB and bifidobacteria.
U2 - 10.1128/AAC.00407-10
DO - 10.1128/AAC.00407-10
M3 - Article
SN - 0066-4804
VL - 54
SP - 2567
EP - 2574
JO - Antimicrobial Agents and Chemotherapy
JF - Antimicrobial Agents and Chemotherapy
IS - 6
ER -